JPRN-UMIN000021202招募中2 期
Chemotherapy using gemcitabine and docetaxel for advanced bone and soft tissue sarcoma - Chemotherapy using gemcitabine and docetaxel for advanced bone and soft tissue sarcoma
agoya City University, Graduate School of Medical Science0 个研究点目标入组 10 人开始时间: 2016年2月26日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 13years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Past history of allegy for gemcitabine or docetaxel 2) Interstitial pneumonitis or pulmonary fibrosis 3) Active infection 4) Pregnancy 5) Lactation 6) Double cancer
研究者
相似试验
未知
不适用
Gemcitabine / Docetaxel combination chemotherapy for non-small cell lung cancer patient of safety confirmation test researchnon-small cell lung cancerJPRN-C000000098agano Prefecture lung cancer chemotherapy Study Group200
已完成
2 期
Chemoradiation with gemcitabine in combination with panitumumab for patients with locally advanced pancreatic cancer.pancreas cancer10017991Pancreatic cancerNL-OMON36705Vrije Universiteit Medisch Centrum63
进行中（未招募）
1 期
Chemoradiation with gemcitabine in combination with panitumumab for patients with locally advanced pancreatic cancer.Inoperable locally advanced pancreatic cancer.MedDRA version: 12.1Level: LLTClassification code 10033606Term: Pancreatic cancer non-resectableEUCTR2010-018327-26-NLVU University Medical Center
招募中
2 期
Phase 2 study of gemcitabine and docetaxel chemotherapy for advanced bone and soft tissue sarcomasadvanced bone and soft tissue sarcomasJPRN-UMIN000031004Kobe University20
招募中
2 期
GD therapy for advanced sarcomasadvanced pretreated bone and soft tissue sarcomasJPRN-jRCTs051180042Hara Hitomi20